Molina Healthcare Q3 2026 Earnings and the Cost of Growth

Farzin Espahani

Strategic Advisor, Insurance Growth, Medicare Distribution, and Compliance

Published October 23, 2026

Molina Healthcare is a health insurer focused on government-funded and government-supported coverage. Its main businesses are Medicaid, Medicare, and individual and family plans sold through the Affordable Care Act (ACA) marketplaces. The company began as a clinic in Long Beach, California, in 1980, serving people who needed affordable access to care. [1]

In Medicaid, Molina receives monthly payments to arrange and pay for covered healthcare services. Its financial performance depends on how well those payments match members' medical needs and the cost of administering their coverage. [2]

My reading of Molina's third-quarter (Q3) 2026 earnings is that its recovery depends on two different jobs: improving the economics of Medicaid and managing a smaller product portfolio responsibly. Marketplace contraction explains the lost premium volume. Medicaid explains the decline in medical margin. Leadership needs separate plans for restoring Medicaid margins and supporting members through product changes.

The regional markets Molina serves

Molina reported approximately 4.9 million members across 21 states at September 30, 2026. Its footprint spans several regions, with different products and service areas in each market. [3]

Representative markets, including affiliated plans such as Senior Whole Health and ConnectiCare. This is not a county-level coverage directory; product availability varies by location and year. [1] [4]

California, New York, Texas, and Washington are particularly significant. Together, they generated approximately 54% of Molina's Medicaid premium revenue in 2025. That concentration makes state reimbursement decisions and contract renewals consequential for the company. [2]

Where Molina has historically been strong

Molina's established strength is managing government health programs, particularly Medicaid. It has also demonstrated an ability to win state contracts and acquire health plans that expand its existing business.

In its 2025 annual report, Molina said that, since launching its growth strategy in 2019, it had achieved a 90% win rate on contract renewals and an 80% win rate on new contract bids. It also reported securing $9 billion in revenue through acquisitions over that period. These are company-reported measures of procurement and expansion performance. [2]

The earlier quarterly results show that growth had been accompanied by earnings. Between Q3 2022 and Q3 2024, net income increased from $230 million to $326 million. Adjusted diluted earnings per share rose from $4.36 to $6.01. [5] [7]

Expense control also improved. The general and administrative expense ratio declined from 7.1% in Q3 2022 to 6.5% in Q3 2024. Molina attributed its 2024 revenue growth to new contracts, acquisitions, and expansion within existing markets. [5] [7]

Molina Q3 earnings comparison from 2022 through 2026

The table compares the three months ended September 30 in each year. Dollar figures are in millions, except per-share amounts. Generally accepted accounting principles (GAAP) apply to the reported income figures; adjusted earnings per share are Molina's supplemental non-GAAP measure.

Sources: Molina Q3 earnings releases for 2022, 2023, 2024, 2025, and 2026. VHealth calculations: net margin = net income / total revenue. MCR uses premium revenue as denominator; G&A ratio uses total revenue.

These are reported company results across a changing portfolio. Acquisitions, contract changes, pricing, and membership mix affect comparability. Adjusted measures reflect each year's disclosed exclusions.

Why Molina is retaining less profit from its revenue

From Q3 2022 to Q3 2024, Molina's revenue and net income increased together. In Q3 2025, revenue continued to grow, but net income fell to $79 million. By Q3 2026, revenue had declined and net income had fallen again, to $38 million. [5] [9]

Across the full comparison, Q3 2026 revenue was 39.8% higher than in Q3 2022, while net income was 83.5% lower. Net margin narrowed from approximately 2.90% to 0.34%. Those calculations show how much less profit the business retained from a substantially larger revenue base. [5] [9]

Administrative expense control continued, with the expense ratio reaching 6.4%. Medical care costs absorbed a larger share of premiums, however, limiting the benefit of those administrative efficiencies. [9]

Medical costs explain much of the margin pressure

The medical care ratio (MCR) measures medical care costs as a percentage of premium revenue. Comparing the business lines shows where pressure developed.

Sources: Molina Q3 segment disclosures for 2022, 2023, 2024, 2025, and 2026. These are company-reported quarterly ratios, not regulatory medical loss ratio rebate calculations.

The Medicaid warning was visible before consolidated earnings fell. In Q3 2024, Molina produced the highest net income in this five-year comparison, yet its Medicaid MCR had already reached 90.5%. Marketplace's ratio was 73.0% that same quarter, masking the Medicaid deterioration in the consolidated figure.

Medicaid's ratio increased each year in the comparison. Marketplace then deteriorated sharply in 2025, when Molina reported utilization above the level supported by risk adjustment revenue. [8]

The consolidated ratio rose from 88.4% in 2022 to 92.9% in 2026. For every $100 of premium revenue, the amount remaining after medical care costs declined from $11.60 to $7.10, before administration and other expenses. [5] [9]

What drove the 2026 decline in revenue and medical margin

The segment changes show why premium growth and margin recovery need separate measures.

VHealth calculations: Q3 2026 minus Q3 2025, from Molina's segment disclosures. Medical margin is premium revenue less medical costs, before administrative and other expenses. [3]

Marketplace accounted for more than the entire consolidated premium decline; growth elsewhere partly offset it. Medicaid accounted for more than the entire decline in medical margin, partly offset by Medicare. Stabilizing Marketplace volume would leave the central Medicaid earnings problem unresolved.

On the earnings call, management projected approximately 4.5% Medicaid rate increases for 2026 against 5.5% medical cost growth. That gap helps explain why additional premium revenue has not restored historical margins. [10]

Molina's Medicare exit is limited to a specific product. It plans to exit traditional Medicare Advantage Prescription Drug (MAPD) coverage in 2027 while continuing to serve people eligible for both Medicare and Medicaid. Management expects the exiting product to lose approximately $1 per share in 2026. [10]

Marketplace is shrinking deliberately. Membership fell from 713,000 to 267,000. Molina cited its product and pricing strategy. Management plans to reduce the Marketplace footprint to seven states in 2027, with the aim of reaching at least breakeven. [10]

What payer leaders should watch in the recovery

Molina reaffirmed its 2026 outlook for approximately $42 billion in premium revenue and adjusted diluted earnings per share of at least $5.25. Management also described preliminary 2027 assumptions supporting more than $9.50 in adjusted earnings per share. Formal initial 2027 guidance is expected in February 2027. [10]

For payer, provider, and distribution leaders, I would judge the recovery against four operating tests.

VHealth's discussion of member handoff and retention describes the operational connections between enrollment, onboarding, and continued coverage.

Molina's next results should show whether reimbursement and portfolio changes restore the amount retained after medical costs. The stronger evidence of recovery would be improving Medicaid economics alongside dependable access, accurate provider payments, and completed member transitions. Higher enrollment or another contract award would establish only part of that case.